Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at the beginning at Jun. 30, 2019 $ 16,594 $ 1 $ 127,327 $ (108,870) $ (1,864)
Balance at the beginning (In shares) at Jun. 30, 2019   856,765      
Common stock sold for cash, net of issuance costs of $240 1,720   1,720    
Common stock sold for cash, net of issuance costs of $240, Shares   186,666      
Issuance of pre-funded warrants, net of transaction costs of $240 50   50    
Share-based compensation 55   55    
Forfeiture of share-based payments     (61) 61  
Foreign currency translation loss (Gain) (304)       (304)
Net loss (1,147)     (1,147)  
Balance at end (In shares) at Sep. 30, 2019   1,043,431      
Balance at end at Sep. 30, 2019 16,968 $ 1 129,091 (109,956) (2,168)
Balance at the beginning at Jun. 30, 2019 16,594 $ 1 127,327 (108,870) (1,864)
Balance at the beginning (In shares) at Jun. 30, 2019   856,765      
Foreign currency translation loss (Gain) (869)        
Net loss (5,339)        
Balance at end (In shares) at Mar. 31, 2020   1,070,957      
Balance at end at Mar. 31, 2020 12,336 $ 1 128,897 (113,829) (2,733)
Balance at the beginning at Sep. 30, 2019 16,968 $ 1 129,091 (109,956) (2,168)
Balance at the beginning (In shares) at Sep. 30, 2019   1,043,431      
Exercise of pre-funded warrants, Shares   27,526      
Share-based compensation 37   37    
Forfeiture of share-based payments     (319) 319  
Foreign currency translation loss (Gain) 336       336
Net loss (2,090)     (2,090)  
Balance at end (In shares) at Dec. 31, 2019   1,070,957      
Balance at end at Dec. 31, 2019 15,251 $ 1 128,809 (111,727) (1,832)
Share-based compensation 88   88    
Foreign currency translation loss (Gain) (901)       (901)
Net loss (2,102)     (2,102)  
Balance at end (In shares) at Mar. 31, 2020   1,070,957      
Balance at end at Mar. 31, 2020 12,336 $ 1 128,897 (113,829) (2,733)
Balance at the beginning at Jun. 30, 2020 10,238 $ 1 128,826 (116,636) (1,953)
Balance at the beginning (In shares) at Jun. 30, 2020   1,108,374      
Share-based compensation 38   38    
Forfeiture of share-based payments     (14) 14  
Foreign currency translation loss (Gain) 178       178
Net loss (2,718)     (2,718)  
Balance at end (In shares) at Sep. 30, 2020   1,108,374      
Balance at end at Sep. 30, 2020 7,736 $ 1 128,850 (119,340) (1,775)
Balance at the beginning at Jun. 30, 2020 10,238 $ 1 128,826 (116,636) (1,953)
Balance at the beginning (In shares) at Jun. 30, 2020   1,108,374      
Foreign currency translation loss (Gain) 362        
Net loss (9,879)        
Balance at end (In shares) at Mar. 31, 2021   4,818,050      
Balance at end at Mar. 31, 2021 10,930 $ 5 138,632 (126,116) (1,591)
Balance at the beginning at Sep. 30, 2020 7,736 $ 1 128,850 (119,340) (1,775)
Balance at the beginning (In shares) at Sep. 30, 2020   1,108,374      
Issuance of pre-funded warrants, net of transaction costs of $240 9,851 $ 3 9,848    
Issuance of pre-funded warrants, net of transaction costs of $240, Shares   3,150,514      
Exercise of pre-funded warrants, Shares   281,581      
Share-based compensation 82   82    
Forfeiture of share-based payments     (385) 385  
Foreign currency translation loss (Gain) 208       208
Net loss (3,252)     (3,252)  
Balance at end (In shares) at Dec. 31, 2020   4,540,469      
Balance at end at Dec. 31, 2020 14,625 $ 4 138,395 (122,207) (1,567)
Exercise of pre-funded warrants, Shares   277,581      
Exercise of pre-funded warrants 3 $ 1 2    
Share-based compensation 235   235    
Foreign currency translation loss (Gain) (24)       (24)
Net loss (3,909)     (3,909)  
Balance at end (In shares) at Mar. 31, 2021   4,818,050      
Balance at end at Mar. 31, 2021 $ 10,930 $ 5 $ 138,632 $ (126,116) $ (1,591)